228 related articles for article (PubMed ID: 12749300)
1. IFN-alpha: therapeutic options in HIV and HIV/HCV, HIV/HBV dual infection.
Jablonowski H
Infection; 2003 Mar; 31(2):131-3. PubMed ID: 12749300
[TBL] [Abstract][Full Text] [Related]
2. HIV/Hepatitis B and C co-infection: pathogenic interactions, natural history and therapy.
Chung RT; Kim AY; Polsky B
Antivir Chem Chemother; 2001; 12 Suppl 1():73-91. PubMed ID: 11594692
[TBL] [Abstract][Full Text] [Related]
3. HBV plus HCV, HCV plus HIV, HBV plus HIV.
Park JS; Saraf N; Dieterich DT
Curr Gastroenterol Rep; 2006 Feb; 8(1):67-74. PubMed ID: 16510037
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of HIV-HCV and HBV-HCV co-infection].
Jmelnitzky AC; Jorge O; Manero E
Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S46-8. PubMed ID: 20214301
[No Abstract] [Full Text] [Related]
5. Recent advances in the treatment of HIV/HBV and HIV/HCV co-infection.
Masgala A; Bonovas S; Nikolopoulos GK
Mini Rev Med Chem; 2012 Aug; 12(9):890-904. PubMed ID: 22530578
[TBL] [Abstract][Full Text] [Related]
6. The impact of human immunodeficiency virus on viral hepatitis.
Mallet V; Vallet-Pichard A; Pol S
Liver Int; 2011 Jan; 31 Suppl 1():135-9. PubMed ID: 21205151
[TBL] [Abstract][Full Text] [Related]
7. Lack of interference between ribavirin and nucleosidic analogues in HIV/HCV co-infected individuals undergoing concomitant antiretroviral and anti-HCV combination therapy.
Landau A; Batisse D; Piketty C; Jian R; Kazatchkine MD
AIDS; 2000 Aug; 14(12):1857-8. PubMed ID: 10985327
[No Abstract] [Full Text] [Related]
8. Opportunistic infections update.
Proj Inf Perspect; 1998 Dec; (26):5-6. PubMed ID: 11366497
[TBL] [Abstract][Full Text] [Related]
9. Comment on Neumann et al. 'Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients'.
D'Offizi G; Martini F; Rozera G; Abbate I; Capobianchi MR; Narciso P; Dianzani F
AIDS; 2008 Jan; 22(2):321. PubMed ID: 18097242
[No Abstract] [Full Text] [Related]
10. Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.
Liu CJ; Chuang WL; Lee CM; Yu ML; Lu SN; Wu SS; Liao LY; Chen CL; Kuo HT; Chao YC; Tung SY; Yang SS; Kao JH; Liu CH; Su WW; Lin CL; Jeng YM; Chen PJ; Chen DS
Gastroenterology; 2009 Feb; 136(2):496-504.e3. PubMed ID: 19084016
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with interferon-alpha and ribavirin in patients with dual hepatitis B and hepatitis C virus infection.
Hung CH; Lee CM; Lu SN; Wang JH; Tung HD; Chen CH; Changchien CS
J Gastroenterol Hepatol; 2005 May; 20(5):727-32. PubMed ID: 15853986
[TBL] [Abstract][Full Text] [Related]
12. Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients.
Neumann A; Polis M; Rozenberg L; Jackson J; Reitano K; McLaughlin M; Koratich C; Dewar R; Masur H; Haagmans B; Kottilil S
AIDS; 2007 Sep; 21(14):1855-65. PubMed ID: 17721093
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus infection: co-infection with HIV and HBV.
Cropley I; Main J
Baillieres Best Pract Res Clin Gastroenterol; 2000 Apr; 14(2):265-75. PubMed ID: 10890321
[TBL] [Abstract][Full Text] [Related]
14. HIV and hepatitis co-infection: a consensus for treatment?
Lumb J
Lancet Infect Dis; 2005 Apr; 5(4):202. PubMed ID: 15834972
[No Abstract] [Full Text] [Related]
15. Sustained virological response after early antiviral treatment of acute hepatitis C virus and HIV coinfection.
Schulze Zur Wiesch J; Pieper D; Stahmer I; Eiermann T; Buggisch P; Lohse A; Hauber J; van Lunzen J
Clin Infect Dis; 2009 Aug; 49(3):466-72. PubMed ID: 19580412
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of pegylated interferon alpha-2a therapy for chronic hepatitis C in HIV-infected patients with haemophilia.
Zhang RF; Sun HQ; Huang Q; Wang JR; Zhang XX; Liu XN; Ma Q; Lu HZ
Haemophilia; 2010 May; 16(3):502-7. PubMed ID: 20028427
[TBL] [Abstract][Full Text] [Related]
17. Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis.
Zignego AL; Fontana R; Puliti S; Barbagli S; Monti M; Careccia G; Giannelli F; Giannini C; Buzzelli G; Brunetto MR; Bonino F; Gentilini P
J Med Virol; 1997 Apr; 51(4):313-8. PubMed ID: 9093946
[TBL] [Abstract][Full Text] [Related]
18. Late hepatitis B virus relapse in patients co-infected with hepatitis B virus and hepatitis C virus after antiviral treatment with pegylated interferon-a2b and ribavirin.
Potthoff A; Berg T; Wedemeyer H;
Scand J Gastroenterol; 2009; 44(12):1487-90. PubMed ID: 19900055
[TBL] [Abstract][Full Text] [Related]
19. HCV infection in the setting of HIV: prevalence, disease, treatment.
Laurence J
AIDS Read; 2006 Mar; 16(3):115-6. PubMed ID: 16538952
[No Abstract] [Full Text] [Related]
20. Anti-HIV agents. Hepatitis C treatment and possible interactions with anti-HIV drugs.
TreatmentUpdate; 2004; 16(3):2-4. PubMed ID: 17216833
[No Abstract] [Full Text] [Related]
[Next] [New Search]
